Search results
Results from the WOW.Com Content Network
Acute erythrocyte leukemia (AEL) is an extremely rare form of acute myeloid leukemia (less than 1% of AML cases [1]) which is characterized by neoplastic proliferation of erythroid cells with features of maturation arrest (increased erythroblasts) and high prevalence of biallelic TP53 alterations.
Autoimmune disease.; Thymoma. [2]Viral infections such as HIV, herpes, parvovirus B19 (Fifth disease), [3] or hepatitis. [citation needed]Lymphoproliferative.Association of pure red cell aplasia with T-cell large granular lymphocyte leukemia is well recognized, especially in China.
Blood doping – Athletes who take erythropoietin-stimulating agents or receive blood transfusions to increase their red blood cell mass. [ 28 ] Post-transplant erythrocytosis – About 10–15% of patients after renal transplantation are found to have polycythemia at 24 months after transplantation, which can be associated with increased ...
This is an incomplete list, which may never be able to satisfy certain standards for completion.. There are many conditions of or affecting the human hematologic system—the biological system that includes plasma, platelets, leukocytes, and erythrocytes, the major components of blood and the bone marrow.
Red blood cell indices are blood tests that provide information about the hemoglobin content and size of red blood cells. Abnormal values indicate the presence of anemia and which type of anemia it is.
measure of the range of variation of red blood cell volume that is reported as part of a standard complete blood count. Red blood cell distribution width ( RDW ), as well as various types thereof ( RDW-CV or RCDW and RDW-SD ), is a measure of the range of variation of red blood cell (RBC) volume that is reported as part of a standard complete ...
The myeloid cell line normally produces granulocytes, erythrocytes, thrombocytes, macrophages and mast cells; the lymphoid cell line produces B, T, NK and plasma cells. Lymphomas, lymphocytic leukemias, and myeloma are from the lymphoid line, while acute and chronic myelogenous leukemia, myelodysplastic syndromes and myeloproliferative diseases ...
If all cancer patients survived and cancer occurred randomly, the normal lifetime odds of developing a second primary cancer (not the first cancer spreading to a new site) would be one in nine. [29] However, cancer survivors have an increased risk of developing a second primary cancer, and the odds in 2003 were about one in 4.5. [ 29 ]